Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BI 1265162 in Cystic Fibrosis (BALANCE-CF 1)
NCT04059094Phase 2Terminated
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2019
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of BI 1265162 in cystic fibrosis (CF), sponsored by Boehringer Ingelheim. Started Sep 2019; status: terminated.
02
Drugs
BI 1265162
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT04059094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04059094.